# Phase 149O.20L.7O.2X.1 Complete — Codex-Ox Agent Registration and Generic Intake Compatibility Independent Verification

**Verdict: INDEPENDENTLY VERIFIED — CODEX-OX AGENT REGISTRATION AND
GENERIC INTAKE COMPATIBILITY COMPLETE.** 0 Blocking findings.
Post-`v0.3.0` development; the published `v0.3.0` tag/release/package
version are untouched. Verification-only — no production code was
changed.

Re-derived, directly from production source and git history rather than
from 2X's own report, tests, or documentation conclusions, whether
`codex-ox` is coherently and truthfully supported as a PCAE
agent/session identity. Reconstructed pre-2X baseline behavior from the
parent commit of `7dc2f0fa`, confirming the core governance agent lock
and generic-intake-provenance path were and remain identity-agnostic by
design, untouched by 2X's diff. Performed a fresh full-vocabulary
inventory confining `codex-ox` to exactly two production files
(`agent.py`, `session.py`) rather than assuming 2X's own five-surface
count.

Independently exercised — not merely read — every deliberate-omission
surface (backend invocation registry, runtime-probe list,
remote-execution allow-list), confirming no path from registration to
executable dispatch and no silent fallback to a real backend anywhere.
Verified literal identity preservation end-to-end, capability/config-
registry accuracy against `codex-local`'s entry, forged-producer-
authority-field injection (zero effect on canonical authority fields),
out-of-scope rejection, no-lock and unregistered-custom-identity
compatibility, absence of any dedicated adapter/parser or
network/subprocess-dispatch code in the diff, absence of authentication
overclaim in source, and current documentation truthfulness.

Both carried-forward 2W.1 NON-BLOCKING findings (malformed-agent-lock
exception; empty-`agent_id` fallback) independently reproduced and
confirmed identity-agnostic, unrelated to `codex-ox`.

## Summary

`codex-ox` support scope: first-class agent/session identity, bootstrap
recognition, governance-lock provenance, generic intake compatibility.
PCAE-native Codex-Ox execution backend: not implemented. OpenRouter/Ox
transport: not implemented. Producer provenance: descriptive,
non-authenticating, non-authorizing. Dedicated adapter: none. Native
parser: none. Runtime: `Observed`/`observe`/`unavailable`.

## Test Evidence

37 fresh independent tests (none reusing 2X's own test functions) plus
full regression: 2X's own suite, 2W/2W.1/2U.2/2U.3/2U.4 suites,
`test_review.py`, `test_canonical_artifact_promotion.py`,
`test_mutation_permission_promotion_integration.py` (200 passed);
`test_agent.py` + `test_session.py` full files (4381 passed, 0 failed).
4618 tests total run and passing this phase.

Two independent full `fast_green` sweeps (fixed `git worktree` clean
baseline vs. this phase's own working tree): 334 vs. 335 failed (343 vs.
344 total incl. 9 errors each). The single delta,
`test_shell_gate.py::TestAuditPersistence::test_audit_verify_cli`,
independently reproduced as a resource-contention subprocess-timeout
artifact of this verification session's own concurrent heavy test runs
(passes in isolation in 9.37s) — zero attributable regressions.

## Governance

`pcae health`: healthy. `pcae check`: passed. `pcae status coherence`:
coherent. `pcae runtime inspect`: `execution_capability: unavailable`,
unchanged. v0.3.0 tag/release/package: untouched. Article:
unchanged/unpublished. Private `~/repos/pcae-deepseek-research`: not
inspected.

## Recommended Next Phase

A small **Post-v0.3 Release Hardening and Release Scope Reassessment**
phase (not another agent-specific implementation phase) — accumulated
post-v0.3 capability set, `v0.3.1` vs. next-minor release scope, whether
to repair the two carried-forward W.1 findings before release,
release-critical documentation truthfulness, packaged-capability set,
installation/smoke validation, supported-agent matrix, article-rewrite
readiness.

Full text:
`docs/PHASE_149O_20L_7O_2X_1_CODEX_OX_AGENT_REGISTRATION_AND_GENERIC_INTAKE_COMPATIBILITY_INDEPENDENT_VERIFICATION.md`.
